News Release 11-Feb-2026
Vanderbilt Health to lead expanded multisite study of immunomodulation in long COVID
https://www.eurekalert.org/news-releases/1116267
The Randomized Double-Blind Placebo-Controlled Trial EValuating Baricitinib on PERSistent NEurologic and Cardiopulmonary symptoms of #LongCOVID (REVERSE-LC)
Hashtags:
@longcovid
#LongCovid #PASC #PwLC #postcovid #postcovid19 #LC #Covidlonghaulers #PostCovidSyndrome #longhaulers #COVIDBrain #NeuroPASC



















